|
- Drug Utilization Review - AMCP. org
Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met
- Drug Utilization Review (DUR) | Medicaid
Drug Utilization Review (DUR) Since 1993, section 1927 (g) of the Act has required each state to develop a DUR program targeted, in part, at reducing clinical abuse and misuse of outpatient prescription drugs covered under the State’s Medicaid Program
- What does DUR mean to you? Definitions and purposes abound
DUR first appeared with the Omnibus Budget Reconciliation Act of 1990 (OBRA ’90) Its goals: Reduce Medicaid fraud and ensure that patients receive appropriate medications
- DUR: Prospective DUR - California
Prospective Drug Use Review (DUR) is performed electronically at the time a drug is dispensed to a patient This review is designed to identify potential problems such as drug-drug interactions, therapeutic duplication, inappropriate dosage, or duration of therapy
- DUR Definition Meaning - Merriam-Webster
Test your visual vocabulary! The meaning of DUR is major How to use dur in a sentence
- Drug Utilization Review (DUR) - New York State Department of Health
Drug utilization review programs help to ensure that prescriptions for outpatient drugs are appropriate, medically necessary, and not likely to result in adverse medical consequences
- What is a Drug Utilization Review (DUR)? - Definition from Insuranceopedia
A Drug Utilization Review (DUR) is a program designed to enhance the safety and effectiveness of prescription drug use These reviews include studies conducted on drugs prior to their commercial release and public use, as well as ongoing studies after they are prescribed to patients
- Drug Utilization Review Guidance | Medicaid
Drug Utilization Review (DUR) assistance is available to assist state Medicaid agencies in developing, enhancing, implementing, and evaluating regulations and programs to ensure appropriate drug therapy and streamline fraud, misuse and abuse
|
|
|